Patents by Inventor Elizabeth A Flynn

Elizabeth A Flynn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10820976
    Abstract: A padded table for animal massage or body work having a flat square working surface with diagonally situated bumper pads supported on 4 sets of attached folding legs. Table construction includes two adjacent parallel sections joined in the middle with a piano-type hinge so that it may be closed and moved or carried easily as like a suitcase or unfolded to form a flat working surface. The double leg support structure on both sides of the adjacent parallel sections distributes the weight of animals who may move continually across the sections providing unique stability.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: November 3, 2020
    Inventor: Elizabeth A Flynn
  • Publication number: 20190053885
    Abstract: A padded table for animal massage or body work having a flat square working surface with diagonally situated bumper pads supported on 4 sets of attached folding legs. Table construction includes two adjacent parallel sections joined in the middle with a piano-type hinge so that it may be closed and moved or carried easily as like a suitcase or unfolded to form a flat working surface. The double leg support structure on both sides of the adjacent parallel sections distributes the weight of animals who may move continually across the sections providing unique stability.
    Type: Application
    Filed: June 13, 2018
    Publication date: February 21, 2019
    Inventor: Elizabeth A Flynn
  • Patent number: 9409942
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies thereby facilitating rapid isolation and purification of recombinant proteins. The invention further provides methods for producing protein molecular weight ladders for us in protein gel electrophoresis, as well as proteins and protein molecular weight ladders produced by these methods.
    Type: Grant
    Filed: July 25, 2013
    Date of Patent: August 9, 2016
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Deb Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
  • Publication number: 20140097086
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies thereby facilitating rapid isolation and purification of recombinant proteins. The invention further provides methods for producing protein molecular weight ladders for us in protein gel electrophoresis, as well as proteins and protein molecular weight ladders produced by these methods.
    Type: Application
    Filed: July 25, 2013
    Publication date: April 10, 2014
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: Deb K. CHATTERJEE, Mary Longo, Elizabeth Flynn, Robert Oberfelder
  • Patent number: 8519099
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.
    Type: Grant
    Filed: January 13, 2011
    Date of Patent: August 27, 2013
    Assignee: Life Technologies Corporation
    Inventors: Deb Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
  • Patent number: 8389681
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.
    Type: Grant
    Filed: December 29, 2006
    Date of Patent: March 5, 2013
    Assignee: Life Technologies Corporation
    Inventors: Deb K. Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
  • Patent number: 8012715
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.
    Type: Grant
    Filed: December 29, 2006
    Date of Patent: September 6, 2011
    Assignee: Life Technologies Corporation
    Inventors: Deb K. Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
  • Publication number: 20110108420
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.
    Type: Application
    Filed: January 13, 2011
    Publication date: May 12, 2011
    Applicant: LIFE TECHNOLOGIES CORPORATION
    Inventors: DEB K. CHATTERJEE, Mary Longo, Elizabeth Flynn, Robert Oberfelder
  • Publication number: 20080268520
    Abstract: The present invention relates generally to compositions and methods for enhancing recombinational cloning of nucleic acid molecules. In particular, the invention relates to compositions comprising one or more ribosomal proteins and one or more additional protein components required for recombinational cloning. More particularly, the invention relates to such compositions wherein the ribosomal proteins are one or more E. coli ribosomal proteins, still more particularly wherein the ribosomal proteins are selected from the group of E. coli ribosomal proteins consisting of S10, S14, S15, S16, S17, S18, S19, S20, S21, L20, L21, and L23 through L34, and most particularly S20, L27, and S15. The invention also relates to the use of these compositions in methods for recombinational cloning of nucleic acids, in vitro and in vivo, to provide chimeric DNA molecules that have particular characteristics and/or DNA segments.
    Type: Application
    Filed: October 6, 2006
    Publication date: October 30, 2008
    Applicant: INVITROGEN CORPORATION
    Inventors: Gary F. Gerard, Elizabeth Flynn, A-Li W. Hu
  • Patent number: 7265206
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.
    Type: Grant
    Filed: January 11, 2006
    Date of Patent: September 4, 2007
    Assignee: Invitrogen Corporation
    Inventors: Deb K. Chatterjee, Mary C. Longo, Elizabeth Flynn, Robert W. Oberfelder
  • Patent number: 7259242
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.
    Type: Grant
    Filed: January 11, 2006
    Date of Patent: August 21, 2007
    Assignee: Invitrogen Corporation
    Inventors: Deb K. Chatterjee, Mary C. Longo, Elizabeth Flynn, Robert W. Oberfelder
  • Publication number: 20070190606
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.
    Type: Application
    Filed: December 29, 2006
    Publication date: August 16, 2007
    Applicant: INVITROGEN CORPORATION
    Inventors: Deb Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
  • Publication number: 20070184527
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.
    Type: Application
    Filed: December 29, 2006
    Publication date: August 9, 2007
    Applicant: INVITROGEN CORPORATION
    Inventors: Deb CHATTERJEE, Mary LONGO, Elizabeth FLYNN, Robert OBERFELDER
  • Patent number: 7223566
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.
    Type: Grant
    Filed: December 8, 2003
    Date of Patent: May 29, 2007
    Assignee: Invitrogen Corporation
    Inventors: Deb K Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
  • Publication number: 20060286633
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.
    Type: Application
    Filed: January 11, 2006
    Publication date: December 21, 2006
    Applicant: Invitrogen Corporation
    Inventors: Deb Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
  • Publication number: 20060269992
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.
    Type: Application
    Filed: January 11, 2006
    Publication date: November 30, 2006
    Applicant: Invitrogen Corporation
    Inventors: Deb Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
  • Publication number: 20060074519
    Abstract: The medication administration accuracy of a number of hospitals is compared and reports are produced. Data is received from each of the reporting hospitals including dosage error information and matching characteristics on which the hospitals can be compared. The received data is merged to provide a medication accuracy comparison database, and comparison groups are established based on a predetermined characteristic of each hospital. An accuracy rate is calculated for each hospital, and a report is produced comparing the medication administration accuracy of each reporting hospital with other hospitals in the associated comparison group.
    Type: Application
    Filed: August 19, 2005
    Publication date: April 6, 2006
    Inventors: Kenneth Barker, Elizabeth Flynn
  • Patent number: 6964861
    Abstract: The present invention relates generally to compositions and methods for enhancing recombinational cloning of nucleic acid molecules. In particular, the invention relates to compositions comprising one or more ribosomal proteins and one or more additional protein components required for recombinational cloning. More particularly, the invention relates to such compositions wherein the ribosomal proteins are one or more E. coli ribosomal proteins, still more particularly wherein the ribosomal proteins are selected from the group of E. coli ribosomal proteins consisting of S10, S14, S15, S16, S17, S18, S19, S20, S21, L20, L21, and L23 through L34, and most particularly S20, L27, and S15. The invention also relates to the use of these compositions in methods for recombinational cloning of nucleic acids, in vitro and in vivo, to provide chimeric DNA molecules that have particular characteristics and/or DNA segments.
    Type: Grant
    Filed: November 12, 1999
    Date of Patent: November 15, 2005
    Assignee: Invitrogen Corporation
    Inventors: Gary F. Gerard, Elizabeth Flynn, A-Li W. Hu
  • Publication number: 20040204563
    Abstract: The current invention provides methods for producing a polypeptide as inclusion bodies in bacterial host cells. The present methods are carried out by forming a gene construct comprising the genetic sequence encoding a polypeptide operatively linked to that of an inclusion partner protein, such as E. coli thioredoxin or a modified E. coli thioredoxin, such that host cells comprising the gene construct produce the polypeptide as intracellular inclusion bodies. The methods of the present invention facilitate the rapid isolation and purification of recombinant proteins. In addition, the present methods may be useful for producing polypeptides or proteins which are small and are typically difficult to express, as well as those proteins that are toxic to host cells such as E. coli. The present invention also provides plasmids, vectors and host cells to be used in the present invention for production of polypeptides, and methods of production of polypeptides using these vectors and host cells.
    Type: Application
    Filed: December 8, 2003
    Publication date: October 14, 2004
    Applicant: Invitrogen Corporation
    Inventors: Deb K. Chatterjee, Mary Longo, Elizabeth Flynn, Robert Oberfelder
  • Patent number: D1026640
    Type: Grant
    Filed: June 2, 2021
    Date of Patent: May 14, 2024
    Assignee: Dyson Technology Limited
    Inventors: Andrew Drummond Flynn, Imogen Elizabeth Adams, Emily Mary Menzies, George Joseph Moone